SPAG9 and Familial prostate cancer: Our analysis of the reported expression pattern of 152 humane prostate tissue samples [28, 29] revealed that both, PRK1 and SPAG9 were significantly overexpressed in prostate cancer tissue, but most importantly also in metastases compared to normal tissue (Figure 6A and 6B).